NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 163.5% | 76.9% | 1,040.7% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 56.5% | 31.3% | 23.4% | -41.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -46.5% | -343% | -602.1% | -5,790.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -39.6% | -356.7% | -607.4% | -5,842% |
| EPS Diluted | -0.09 | -0.46 | -0.65 | -0.63 |
| % Growth | 80.4% | 29.2% | -3.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |